Rankings
▼
Calendar
DXCM Q1 2023 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena
DXCM
DexCom, Inc.
$27B
Q1 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$742M
+17.9% YoY
Gross Profit
$463M
62.4% margin
Operating Income
$47M
6.4% margin
Net Income
$49M
6.6% margin
EPS (Diluted)
$0.12
QoQ Revenue Growth
-9.0%
Cash Flow
Operating Cash Flow
$155M
Free Cash Flow
$81M
Stock-Based Comp.
$35M
Balance Sheet
Total Assets
$5.5B
Total Liabilities
$3.3B
Stockholders' Equity
$2.2B
Cash & Equivalents
$623M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$742M
$629M
+17.9%
Gross Profit
$463M
$398M
+16.2%
Operating Income
$47M
$41M
+14.3%
Net Income
$49M
$97M
-50.1%
Geographic Segments
UNITED STATES
$526M
71%
Non-US
$216M
29%
← FY 2023
All Quarters
Q2 2023 →